학술논문
Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers
Document Type
Article
Source
In iScience 17 March 2023 26(3)
Subject
Language
ISSN
2589-0042